Clay B. Siegall

Insider Reports History

Entity
Individual
Location
21823 30 Th Dr Se, Bothell, WA
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Clay B. Siegall:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Seagen Inc. President & CEO, Director Common Stock 666K $153M $229.00 May 12, 2022 Direct
Immunome Inc. President and CEO, Director Common Stock 520K $5.08M $9.78 Nov 22, 2024 Direct
Immunome Inc. President and CEO, Director Stock option (right to buy) 800K Aug 9, 2024 Direct
Seagen Inc. President & CEO, Director Non-Qualified Stock Option (right to buy) 51.1K May 12, 2022 Direct
Shattuck Labs, Inc. Director Stock Option (Right to Buy) 27.7K Jun 21, 2024 Direct
Nurix Therapeutics, Inc. Director Director Stock Option (right to buy) 17.5K May 5, 2022 Direct
Tourmaline Bio, Inc. Director Stock Option (Right to Buy) 15K Jun 5, 2024 Direct

Insider Reports Filed by Clay B. Siegall

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMNM Immunome Inc. Nov 21, 2024 2 $962K 4 Nov 25, 2024 President and CEO, Director
IMNM Immunome Inc. Aug 9, 2024 1 $0 4 Aug 13, 2024 President and CEO, Director
STTK Shattuck Labs, Inc. Jun 21, 2024 1 $0 4 Jun 21, 2024 Director
TRML Tourmaline Bio, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
IMNM Immunome Inc. May 20, 2024 2 $1.39M 4 May 21, 2024 President and CEO, Director
STTK Shattuck Labs, Inc. Mar 6, 2024 1 $0 4 Mar 8, 2024 Director
STTK Shattuck Labs, Inc. Mar 1, 2024 0 $0 3 Mar 8, 2024 Director
TRML Tourmaline Bio, Inc. Dec 13, 2023 1 $0 4 Dec 15, 2023 Director
TRML Tourmaline Bio, Inc. Dec 13, 2023 0 $0 3 Dec 15, 2023 Director
IMNM Immunome Inc. Oct 2, 2023 1 $1M 4 Oct 4, 2023 President and CEO, Director
IMNM Immunome Inc. Oct 2, 2023 0 $0 3 Oct 4, 2023 President and CEO, Director
SGEN Seagen Inc. May 12, 2022 6 -$1.7M 4 May 13, 2022 President & CEO, Director
NRIX Nurix Therapeutics, Inc. May 5, 2022 1 $0 4 May 6, 2022 Director
SGEN Seagen Inc. Apr 20, 2022 1 -$272K 4 Apr 22, 2022 President & CEO, Director
SGEN Seagen Inc. Apr 7, 2022 21 -$2.18M 4 Apr 8, 2022 President and CEO, Director
SGEN Seagen Inc. Mar 7, 2022 15 -$1.84M 4 Mar 9, 2022 President & CEO, Director
SGEN Seagen Inc. Feb 7, 2022 15 -$1.94M 4 Feb 9, 2022 President & CEO, Director
SGEN Seagen Inc. Jan 7, 2022 12 -$2.02M 4 Jan 11, 2022 President & CEO, Director
SGEN Seagen Inc. Dec 20, 2021 1 -$184K 4 Dec 22, 2021 President & CEO, Director
SGEN Seagen Inc. Dec 7, 2021 15 -$5.57M 4 Dec 9, 2021 President & CEO, Director
SGEN Seagen Inc. Sep 23, 2021 1 $119K 4 Sep 27, 2021 President & CEO, Director
SGEN Seagen Inc. Aug 31, 2021 2 -$2.4M 4 Sep 2, 2021 President & CEO, Director
SGEN Seagen Inc. Aug 27, 2021 6 -$10.1M 4 Aug 31, 2021 President and CEO, Director
SGEN Seagen Inc. Aug 16, 2021 4 -$431K 4 Aug 18, 2021 President & CEO, Director
SGEN Seagen Inc. Aug 5, 2021 18 -$4.31M 4 Aug 6, 2021 President & CEO, Director
SGEN Seagen Inc. Jul 1, 2021 21 -$4.16M 4 Jul 6, 2021 President and CEO, Director
SGEN Seagen Inc. Jun 3, 2021 21 -$3.79M 4 Jun 4, 2021 President and CEO, Director
NRIX Nurix Therapeutics, Inc. May 28, 2021 1 $0 4 Jun 1, 2021 Director
NRIX Nurix Therapeutics, Inc. May 28, 2021 0 $0 3 Jun 1, 2021 Director
SGEN Seagen Inc. May 6, 2021 9 -$3.51M 4 May 7, 2021 President and CEO, Director